Purdue docs use acidity to time cancer drug release; Eternity, PharmaNova partner to develop skin-delivered steroids;

> Researchers at Purdue University have developed nanoparticles that use pH phoresis to improve cancer drug delivery. By focusing on differences in acidity at tumor sites, they were able to control the release therein. Report

> Eternity Healthcare and PharmaNova signed a letter of intent to develop steroids and related drugs for subcutaneous absorption using PharmaNova's NovaSperse nanoparticle technology. Release

> Researchers in China and Chicago have developed a drug-eluting scaffold to deliver chemotherapy to treat pancreatic cancer after surgery. Abstract

> CryoLife's laser fiber-optic delivery system to treat angina snagged FDA premarket approval. The single-use, disposable handset is used with the company's cardiogenesis transmyocardial revascularization system. More

> TWi Pharmaceuticals received U.S. patent allowance for its metformin controlled-release formulation to treat Type 2 diabetes with reduced food effect. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.